Not Yet RecruitingNot Applicable

Correlation Between OCT and Mf-ERG Findings With BCVA in Patients With Macular Dystrophy

30 participantsStarted 2025-09-20

Plain-language summary

Correlation between optical coherence tomography and multifocal electroretinogram findings with visual acuity in patients with macular dystrophy.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients diagnosed with macular dystrophy in Tiba Eye Centre, Egypt, Assiut, during the period of the study Exclusion Criteria: * The patients diagnosed with macular dystrophy refuse to contribute to the study.

What they're measuring

BCVA (best corrected visual acuity)

Timeframe: Day 1/month 3

CMT (central macular thickness) μm Central macular thickness measurement using optical coherence tomography

Timeframe: Day1/month 3

mf-ERG amplituide nV/deg2

Timeframe: Day 1/month 6

Trial details

NCT IDNCT07171541

SponsorNew Valley University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-11-20

View on ClinicalTrials.gov More Macular Dystrophy trials